Convertible Top
Convertible Top market is segmented by Type and by Application. Players, stakeholders, and other ... Read More
1 Study Coverage
1.1 Cardiac Marker Product Introduction
1.2 Market by Type
1.2.1 Global Cardiac Marker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Creatine kinase (CK) MB
1.2.3 Troponin (cTnI and cTnT)
1.2.4 BNP & NT-proBNP
1.2.5 Myogloblin
1.2.6 Others (hs-CRP, D-Dimer, etc.)
1.3 Market by Application
1.3.1 Global Cardiac Marker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cardiac Marker Sales Estimates and Forecasts 2017-2028
2.2 Global Cardiac Marker Revenue Estimates and Forecasts 2017-2028
2.3 Global Cardiac Marker Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cardiac Marker Sales by Region
2.4.1 Global Cardiac Marker Sales by Region (2017-2022)
2.4.2 Global Sales Cardiac Marker by Region (2023-2028)
2.5 Global Cardiac Marker Revenue by Region
2.5.1 Global Cardiac Marker Revenue by Region (2017-2022)
2.5.2 Global Cardiac Marker Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cardiac Marker Sales by Manufacturers
3.1.1 Global Top Cardiac Marker Manufacturers by Sales (2017-2022)
3.1.2 Global Cardiac Marker Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cardiac Marker in 2021
3.2 Global Cardiac Marker Revenue by Manufacturers
3.2.1 Global Cardiac Marker Revenue by Manufacturers (2017-2022)
3.2.2 Global Cardiac Marker Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cardiac Marker Revenue in 2021
3.3 Global Cardiac Marker Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cardiac Marker Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cardiac Marker Sales by Type
4.1.1 Global Cardiac Marker Historical Sales by Type (2017-2022)
4.1.2 Global Cardiac Marker Forecasted Sales by Type (2023-2028)
4.1.3 Global Cardiac Marker Sales Market Share by Type (2017-2028)
4.2 Global Cardiac Marker Revenue by Type
4.2.1 Global Cardiac Marker Historical Revenue by Type (2017-2022)
4.2.2 Global Cardiac Marker Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cardiac Marker Revenue Market Share by Type (2017-2028)
4.3 Global Cardiac Marker Price by Type
4.3.1 Global Cardiac Marker Price by Type (2017-2022)
4.3.2 Global Cardiac Marker Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cardiac Marker Sales by Application
5.1.1 Global Cardiac Marker Historical Sales by Application (2017-2022)
5.1.2 Global Cardiac Marker Forecasted Sales by Application (2023-2028)
5.1.3 Global Cardiac Marker Sales Market Share by Application (2017-2028)
5.2 Global Cardiac Marker Revenue by Application
5.2.1 Global Cardiac Marker Historical Revenue by Application (2017-2022)
5.2.2 Global Cardiac Marker Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cardiac Marker Revenue Market Share by Application (2017-2028)
5.3 Global Cardiac Marker Price by Application
5.3.1 Global Cardiac Marker Price by Application (2017-2022)
5.3.2 Global Cardiac Marker Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cardiac Marker Market Size by Type
6.1.1 North America Cardiac Marker Sales by Type (2017-2028)
6.1.2 North America Cardiac Marker Revenue by Type (2017-2028)
6.2 North America Cardiac Marker Market Size by Application
6.2.1 North America Cardiac Marker Sales by Application (2017-2028)
6.2.2 North America Cardiac Marker Revenue by Application (2017-2028)
6.3 North America Cardiac Marker Market Size by Country
6.3.1 North America Cardiac Marker Sales by Country (2017-2028)
6.3.2 North America Cardiac Marker Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cardiac Marker Market Size by Type
7.1.1 Europe Cardiac Marker Sales by Type (2017-2028)
7.1.2 Europe Cardiac Marker Revenue by Type (2017-2028)
7.2 Europe Cardiac Marker Market Size by Application
7.2.1 Europe Cardiac Marker Sales by Application (2017-2028)
7.2.2 Europe Cardiac Marker Revenue by Application (2017-2028)
7.3 Europe Cardiac Marker Market Size by Country
7.3.1 Europe Cardiac Marker Sales by Country (2017-2028)
7.3.2 Europe Cardiac Marker Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cardiac Marker Market Size by Type
8.1.1 Asia Pacific Cardiac Marker Sales by Type (2017-2028)
8.1.2 Asia Pacific Cardiac Marker Revenue by Type (2017-2028)
8.2 Asia Pacific Cardiac Marker Market Size by Application
8.2.1 Asia Pacific Cardiac Marker Sales by Application (2017-2028)
8.2.2 Asia Pacific Cardiac Marker Revenue by Application (2017-2028)
8.3 Asia Pacific Cardiac Marker Market Size by Region
8.3.1 Asia Pacific Cardiac Marker Sales by Region (2017-2028)
8.3.2 Asia Pacific Cardiac Marker Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cardiac Marker Market Size by Type
9.1.1 Latin America Cardiac Marker Sales by Type (2017-2028)
9.1.2 Latin America Cardiac Marker Revenue by Type (2017-2028)
9.2 Latin America Cardiac Marker Market Size by Application
9.2.1 Latin America Cardiac Marker Sales by Application (2017-2028)
9.2.2 Latin America Cardiac Marker Revenue by Application (2017-2028)
9.3 Latin America Cardiac Marker Market Size by Country
9.3.1 Latin America Cardiac Marker Sales by Country (2017-2028)
9.3.2 Latin America Cardiac Marker Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cardiac Marker Market Size by Type
10.1.1 Middle East and Africa Cardiac Marker Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cardiac Marker Revenue by Type (2017-2028)
10.2 Middle East and Africa Cardiac Marker Market Size by Application
10.2.1 Middle East and Africa Cardiac Marker Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cardiac Marker Revenue by Application (2017-2028)
10.3 Middle East and Africa Cardiac Marker Market Size by Country
10.3.1 Middle East and Africa Cardiac Marker Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cardiac Marker Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 HyTest
11.1.1 HyTest Corporation Information
11.1.2 HyTest Overview
11.1.3 HyTest Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 HyTest Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 HyTest Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Overview
11.2.3 Abbott Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Corporation Information
11.3.2 Roche Diagnostics Overview
11.3.3 Roche Diagnostics Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Diagnostics Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Diagnostics Recent Developments
11.4 BG Medicine
11.4.1 BG Medicine Corporation Information
11.4.2 BG Medicine Overview
11.4.3 BG Medicine Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BG Medicine Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BG Medicine Recent Developments
11.5 Biomerieux
11.5.1 Biomerieux Corporation Information
11.5.2 Biomerieux Overview
11.5.3 Biomerieux Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biomerieux Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biomerieux Recent Developments
11.6 Critical Diagnostics
11.6.1 Critical Diagnostics Corporation Information
11.6.2 Critical Diagnostics Overview
11.6.3 Critical Diagnostics Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Critical Diagnostics Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Critical Diagnostics Recent Developments
11.7 DiaDexus
11.7.1 DiaDexus Corporation Information
11.7.2 DiaDexus Overview
11.7.3 DiaDexus Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 DiaDexus Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 DiaDexus Recent Developments
11.8 Response Biomedical
11.8.1 Response Biomedical Corporation Information
11.8.2 Response Biomedical Overview
11.8.3 Response Biomedical Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Response Biomedical Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Response Biomedical Recent Developments
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Corporation Information
11.9.2 Siemens Healthcare Overview
11.9.3 Siemens Healthcare Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Siemens Healthcare Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Siemens Healthcare Recent Developments
11.10 Singulex
11.10.1 Singulex Corporation Information
11.10.2 Singulex Overview
11.10.3 Singulex Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Singulex Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Singulex Recent Developments
11.11 Thermo Scientific
11.11.1 Thermo Scientific Corporation Information
11.11.2 Thermo Scientific Overview
11.11.3 Thermo Scientific Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Thermo Scientific Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Thermo Scientific Recent Developments
11.12 Trinity Biotech
11.12.1 Trinity Biotech Corporation Information
11.12.2 Trinity Biotech Overview
11.12.3 Trinity Biotech Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Trinity Biotech Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Trinity Biotech Recent Developments
11.13 Sunfory
11.13.1 Sunfory Corporation Information
11.13.2 Sunfory Overview
11.13.3 Sunfory Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sunfory Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sunfory Recent Developments
11.14 Lee BioSolutions
11.14.1 Lee BioSolutions Corporation Information
11.14.2 Lee BioSolutions Overview
11.14.3 Lee BioSolutions Cardiac Marker Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Lee BioSolutions Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lee BioSolutions Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cardiac Marker Industry Chain Analysis
12.2 Cardiac Marker Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cardiac Marker Production Mode & Process
12.4 Cardiac Marker Sales and Marketing
12.4.1 Cardiac Marker Sales Channels
12.4.2 Cardiac Marker Distributors
12.5 Cardiac Marker Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cardiac Marker Industry Trends
13.2 Cardiac Marker Market Drivers
13.3 Cardiac Marker Market Challenges
13.4 Cardiac Marker Market Restraints
14 Key Findings in The Global Cardiac Marker Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cardiac Marker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Creatine kinase (CK) MB
Table 3. Major Manufacturers of Troponin (cTnI and cTnT)
Table 4. Major Manufacturers of BNP & NT-proBNP
Table 5. Major Manufacturers of Myogloblin
Table 6. Major Manufacturers of Others (hs-CRP, D-Dimer, etc.)
Table 7. Global Cardiac Marker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Cardiac Marker Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Cardiac Marker Sales by Region (2017-2022) & (K Doses)
Table 10. Global Cardiac Marker Sales Market Share by Region (2017-2022)
Table 11. Global Cardiac Marker Sales by Region (2023-2028) & (K Doses)
Table 12. Global Cardiac Marker Sales Market Share by Region (2023-2028)
Table 13. Global Cardiac Marker Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Cardiac Marker Revenue Market Share by Region (2017-2022)
Table 15. Global Cardiac Marker Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Cardiac Marker Revenue Market Share by Region (2023-2028)
Table 17. Global Cardiac Marker Sales by Manufacturers (2017-2022) & (K Doses)
Table 18. Global Cardiac Marker Sales Share by Manufacturers (2017-2022)
Table 19. Global Cardiac Marker Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Cardiac Marker Revenue Share by Manufacturers (2017-2022)
Table 21. Cardiac Marker Price by Manufacturers (2017-2022) &(USD/Dose)
Table 22. Global Cardiac Marker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Cardiac Marker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Marker as of 2021)
Table 24. Cardiac Marker Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Cardiac Marker Product Offered
Table 26. Date of Manufacturers Enter into Cardiac Marker Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cardiac Marker Sales by Type (2017-2022) & (K Doses)
Table 29. Global Cardiac Marker Sales by Type (2023-2028) & (K Doses)
Table 30. Global Cardiac Marker Sales Share by Type (2017-2022)
Table 31. Global Cardiac Marker Sales Share by Type (2023-2028)
Table 32. Global Cardiac Marker Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Cardiac Marker Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Cardiac Marker Revenue Share by Type (2017-2022)
Table 35. Global Cardiac Marker Revenue Share by Type (2023-2028)
Table 36. Cardiac Marker Price by Type (2017-2022) & (USD/Dose)
Table 37. Global Cardiac Marker Price Forecast by Type (2023-2028) & (USD/Dose)
Table 38. Global Cardiac Marker Sales by Application (2017-2022) & (K Doses)
Table 39. Global Cardiac Marker Sales by Application (2023-2028) & (K Doses)
Table 40. Global Cardiac Marker Sales Share by Application (2017-2022)
Table 41. Global Cardiac Marker Sales Share by Application (2023-2028)
Table 42. Global Cardiac Marker Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Cardiac Marker Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Cardiac Marker Revenue Share by Application (2017-2022)
Table 45. Global Cardiac Marker Revenue Share by Application (2023-2028)
Table 46. Cardiac Marker Price by Application (2017-2022) & (USD/Dose)
Table 47. Global Cardiac Marker Price Forecast by Application (2023-2028) & (USD/Dose)
Table 48. North America Cardiac Marker Sales by Type (2017-2022) & (K Doses)
Table 49. North America Cardiac Marker Sales by Type (2023-2028) & (K Doses)
Table 50. North America Cardiac Marker Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Cardiac Marker Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Cardiac Marker Sales by Application (2017-2022) & (K Doses)
Table 53. North America Cardiac Marker Sales by Application (2023-2028) & (K Doses)
Table 54. North America Cardiac Marker Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Cardiac Marker Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Cardiac Marker Sales by Country (2017-2022) & (K Doses)
Table 57. North America Cardiac Marker Sales by Country (2023-2028) & (K Doses)
Table 58. North America Cardiac Marker Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Cardiac Marker Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Cardiac Marker Sales by Type (2017-2022) & (K Doses)
Table 61. Europe Cardiac Marker Sales by Type (2023-2028) & (K Doses)
Table 62. Europe Cardiac Marker Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Cardiac Marker Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Cardiac Marker Sales by Application (2017-2022) & (K Doses)
Table 65. Europe Cardiac Marker Sales by Application (2023-2028) & (K Doses)
Table 66. Europe Cardiac Marker Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Cardiac Marker Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Cardiac Marker Sales by Country (2017-2022) & (K Doses)
Table 69. Europe Cardiac Marker Sales by Country (2023-2028) & (K Doses)
Table 70. Europe Cardiac Marker Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Cardiac Marker Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Cardiac Marker Sales by Type (2017-2022) & (K Doses)
Table 73. Asia Pacific Cardiac Marker Sales by Type (2023-2028) & (K Doses)
Table 74. Asia Pacific Cardiac Marker Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Cardiac Marker Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Cardiac Marker Sales by Application (2017-2022) & (K Doses)
Table 77. Asia Pacific Cardiac Marker Sales by Application (2023-2028) & (K Doses)
Table 78. Asia Pacific Cardiac Marker Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Cardiac Marker Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Cardiac Marker Sales by Region (2017-2022) & (K Doses)
Table 81. Asia Pacific Cardiac Marker Sales by Region (2023-2028) & (K Doses)
Table 82. Asia Pacific Cardiac Marker Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Cardiac Marker Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Cardiac Marker Sales by Type (2017-2022) & (K Doses)
Table 85. Latin America Cardiac Marker Sales by Type (2023-2028) & (K Doses)
Table 86. Latin America Cardiac Marker Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Cardiac Marker Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Cardiac Marker Sales by Application (2017-2022) & (K Doses)
Table 89. Latin America Cardiac Marker Sales by Application (2023-2028) & (K Doses)
Table 90. Latin America Cardiac Marker Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Cardiac Marker Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Cardiac Marker Sales by Country (2017-2022) & (K Doses)
Table 93. Latin America Cardiac Marker Sales by Country (2023-2028) & (K Doses)
Table 94. Latin America Cardiac Marker Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Cardiac Marker Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Cardiac Marker Sales by Type (2017-2022) & (K Doses)
Table 97. Middle East and Africa Cardiac Marker Sales by Type (2023-2028) & (K Doses)
Table 98. Middle East and Africa Cardiac Marker Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Cardiac Marker Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Cardiac Marker Sales by Application (2017-2022) & (K Doses)
Table 101. Middle East and Africa Cardiac Marker Sales by Application (2023-2028) & (K Doses)
Table 102. Middle East and Africa Cardiac Marker Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Cardiac Marker Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Cardiac Marker Sales by Country (2017-2022) & (K Doses)
Table 105. Middle East and Africa Cardiac Marker Sales by Country (2023-2028) & (K Doses)
Table 106. Middle East and Africa Cardiac Marker Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Cardiac Marker Revenue by Country (2023-2028) & (US$ Million)
Table 108. HyTest Corporation Information
Table 109. HyTest Description and Major Businesses
Table 110. HyTest Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 111. HyTest Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. HyTest Recent Developments
Table 113. Abbott Corporation Information
Table 114. Abbott Description and Major Businesses
Table 115. Abbott Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 116. Abbott Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Abbott Recent Developments
Table 118. Roche Diagnostics Corporation Information
Table 119. Roche Diagnostics Description and Major Businesses
Table 120. Roche Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 121. Roche Diagnostics Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Roche Diagnostics Recent Developments
Table 123. BG Medicine Corporation Information
Table 124. BG Medicine Description and Major Businesses
Table 125. BG Medicine Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 126. BG Medicine Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. BG Medicine Recent Developments
Table 128. Biomerieux Corporation Information
Table 129. Biomerieux Description and Major Businesses
Table 130. Biomerieux Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 131. Biomerieux Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Biomerieux Recent Developments
Table 133. Critical Diagnostics Corporation Information
Table 134. Critical Diagnostics Description and Major Businesses
Table 135. Critical Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 136. Critical Diagnostics Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Critical Diagnostics Recent Developments
Table 138. DiaDexus Corporation Information
Table 139. DiaDexus Description and Major Businesses
Table 140. DiaDexus Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 141. DiaDexus Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. DiaDexus Recent Developments
Table 143. Response Biomedical Corporation Information
Table 144. Response Biomedical Description and Major Businesses
Table 145. Response Biomedical Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 146. Response Biomedical Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Response Biomedical Recent Developments
Table 148. Siemens Healthcare Corporation Information
Table 149. Siemens Healthcare Description and Major Businesses
Table 150. Siemens Healthcare Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 151. Siemens Healthcare Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Siemens Healthcare Recent Developments
Table 153. Singulex Corporation Information
Table 154. Singulex Description and Major Businesses
Table 155. Singulex Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 156. Singulex Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Singulex Recent Developments
Table 158. Thermo Scientific Corporation Information
Table 159. Thermo Scientific Description and Major Businesses
Table 160. Thermo Scientific Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 161. Thermo Scientific Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Thermo Scientific Recent Developments
Table 163. Trinity Biotech Corporation Information
Table 164. Trinity Biotech Description and Major Businesses
Table 165. Trinity Biotech Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 166. Trinity Biotech Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Trinity Biotech Recent Developments
Table 168. Sunfory Corporation Information
Table 169. Sunfory Description and Major Businesses
Table 170. Sunfory Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 171. Sunfory Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Sunfory Recent Developments
Table 173. Lee BioSolutions Corporation Information
Table 174. Lee BioSolutions Description and Major Businesses
Table 175. Lee BioSolutions Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 176. Lee BioSolutions Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Lee BioSolutions Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Cardiac Marker Distributors List
Table 181. Cardiac Marker Customers List
Table 182. Cardiac Marker Market Trends
Table 183. Cardiac Marker Market Drivers
Table 184. Cardiac Marker Market Challenges
Table 185. Cardiac Marker Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Cardiac Marker Product Picture
Figure 3. Global Cardiac Marker Market Share by Type in 2021 & 2028
Figure 3. Creatine kinase (CK) MB Product Picture
Figure 4. Troponin (cTnI and cTnT) Product Picture
Figure 5. BNP & NT-proBNP Product Picture
Figure 6. Myogloblin Product Picture
Figure 7. Others (hs-CRP, D-Dimer, etc.) Product Picture
Figure 8. Global Cardiac Marker Market Share by Application in 2021 & 2028
Figure 9. Myocardial Infarction
Figure 10. Congestive Heart Failure
Figure 11. Acute Coronary Syndrome
Figure 12. Atherosclerosis
Figure 13. Others
Figure 14. Cardiac Marker Report Years Considered
Figure 15. Global Cardiac Marker Sales 2017-2028 (K Doses)
Figure 16. Global Cardiac Marker Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Cardiac Marker Revenue 2017-2028 (US$ Million)
Figure 18. Global Cardiac Marker Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Cardiac Marker Sales Market Share by Region (2017-2022)
Figure 20. Global Cardiac Marker Sales Market Share by Region (2023-2028)
Figure 21. North America Cardiac Marker Sales YoY (2017-2028) & (K Doses)
Figure 22. North America Cardiac Marker Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Cardiac Marker Sales YoY (2017-2028) & (K Doses)
Figure 24. Europe Cardiac Marker Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Cardiac Marker Sales YoY (2017-2028) & (K Doses)
Figure 26. Asia-Pacific Cardiac Marker Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Cardiac Marker Sales YoY (2017-2028) & (K Doses)
Figure 28. Latin America Cardiac Marker Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Cardiac Marker Sales YoY (2017-2028) & (K Doses)
Figure 30. Middle East & Africa Cardiac Marker Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Cardiac Marker Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Cardiac Marker in the World: Market Share by Cardiac Marker Revenue in 2021
Figure 33. Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 35. Global Cardiac Marker Revenue Market Share by Type (2017-2028)
Figure 36. Global Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 37. Global Cardiac Marker Revenue Market Share by Application (2017-2028)
Figure 38. North America Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 39. North America Cardiac Marker Revenue Market Share by Type (2017-2028)
Figure 40. North America Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 41. North America Cardiac Marker Revenue Market Share by Application (2017-2028)
Figure 42. North America Cardiac Marker Sales Share by Country (2017-2028)
Figure 43. North America Cardiac Marker Revenue Share by Country (2017-2028)
Figure 44. U.S. Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 47. Europe Cardiac Marker Revenue Market Share by Type (2017-2028)
Figure 48. Europe Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 49. Europe Cardiac Marker Revenue Market Share by Application (2017-2028)
Figure 50. Europe Cardiac Marker Sales Share by Country (2017-2028)
Figure 51. Europe Cardiac Marker Revenue Share by Country (2017-2028)
Figure 52. Germany Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 53. France Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Cardiac Marker Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Cardiac Marker Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Cardiac Marker Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Cardiac Marker Revenue Share by Region (2017-2028)
Figure 63. China Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 66. India Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 74. Latin America Cardiac Marker Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 76. Latin America Cardiac Marker Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Cardiac Marker Sales Share by Country (2017-2028)
Figure 78. Latin America Cardiac Marker Revenue Share by Country (2017-2028)
Figure 79. Mexico Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Cardiac Marker Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Cardiac Marker Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Cardiac Marker Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Cardiac Marker Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Cardiac Marker Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Cardiac Marker Revenue Share by Country (2017-2028)
Figure 88. Turkey Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Cardiac Marker Revenue (2017-2028) & (US$ Million)
Figure 91. Cardiac Marker Value Chain
Figure 92. Cardiac Marker Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
HyTest Abbott Roche Diagnostics BG Medicine Biomerieux Critical Diagnostics DiaDexus Response Biomedical Siemens Healthcare Singulex Thermo Scientific Trinity Biotech Sunfory Lee BioSolutions
Convertible Top market is segmented by Type and by Application. Players, stakeholders, and other ... Read More
Die Casting Lubricants market is segmented by Type and by Application. Players, stakeholders, and ... Read More
Floor Rugs market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More
Fruit/Vegetable Powder market is segmented by Type and by Application. Players, stakeholders, and ... Read More